Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial

OBJECTIVES: To determine the impact of valaciclovir on HIV disease progression in treatment-naive HIV-positive adults. METHODS: In this fully blind, multicentre, 1:1 randomized placebo-controlled trial, treatment-naive HIV-1-positive adults with CD4 counts 400–900 cells/mm(3) and not meeting contemp...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Antimicrob Chemother
Egile Nagusiak: Tan, Darrell H S, Raboud, Janet M, Szadkowski, Leah, Grinsztejn, Beatriz, Madruga, José Valdez, Figueroa, Maria Ines, Cahn, Pedro, Barton, Simon E, Clarke, Amanda, Fox, Julie, Zubyk, Wendy, Walmsley, Sharon L
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2019
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6337901/
https://ncbi.nlm.nih.gov/pubmed/30376108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dky433
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak